Genomed (WAR:GEN) FCF Margin % : 28.04% (As of Dec. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Genomed FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Genomed's Free Cash Flow for the three months ended in Dec. 2024 was zł2.01 Mil. Genomed's Revenue for the three months ended in Dec. 2024 was zł7.15 Mil. Therefore, Genomed's FCF Margin % for the quarter that ended in Dec. 2024 was 28.04%.

As of today, Genomed's current FCF Yield % is -0.09%.

The historical rank and industry rank for Genomed's FCF Margin % or its related term are showing as below:

WAR:GEN' s FCF Margin % Range Over the Past 10 Years
Min: -21.68 Med: 0.24 Max: 8.52
Current: -0.13

During the past 13 years, the highest FCF Margin % of Genomed was 8.52%. The lowest was -21.68%. And the median was 0.24%.

WAR:GEN's FCF Margin % is ranked better than
53.55% of 211 companies
in the Medical Diagnostics & Research industry
Industry Median: -2.33 vs WAR:GEN: -0.13

Genomed FCF Margin % Historical Data

The historical data trend for Genomed's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomed FCF Margin % Chart

Genomed Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

4.71

8.52

-2.94

7.84

-0.12

Genomed Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial															29.49	-42.14	-6.59	7.67	28.04

Competitive Comparison of Genomed's FCF Margin %

For the Diagnostics & Research subindustry, Genomed's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genomed's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genomed's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Genomed's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Genomed FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Genomed's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-0.027	/	23.007
	=	-0.12 %

Genomed's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	2.005	/	7.151
	=	28.04 %

Genomed FCF Margin % Related Terms

Thank you for viewing the detailed overview of Genomed's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomed Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genomed SA (WAR:GEN) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ulica Ponczowa 12, Warszawa, POL, 02-971

Website

http://www.genomed.pl

Genomed SA assembles outstanding molecular biologists and genetic diagnosticians. The company provides diagnostic service that comprises DNA analysis and congenital diseases diagnostics based on DNA sequencing. It offers Diagnostic service and Service for scientific purposes.